Crossmark

Simultaneously quantifying a novel five-component anti- migraine formulation containing ergotamine, propyphenazone, caffeine, camylofin, and mecloxamine using UV spectrophotometry and chemometric models

Crossref DOI link: https://doi.org/10.1186/s13065-024-01339-4

Published Online: 2024-11-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abbas, Ahmed Emad F. https://orcid.org/0000-0002-7098-8662
Abdelshafi, Nahla A.

Gamal, Mohammed

Halim, Michael K.

Said, Basmat Amal M.

Naguib, Ibrahim A.

Mansour, Mohmeed M. A.

Morshedy, Samir

Salem, Yomna A.
Funding

Funding for this research was provided by:

Taif University (TU-DSPP-2024-49)
License Information

Text and Data Mining valid from 2024-11-20

Version of Record valid from 2024-11-20
More Information

Article History

Received: 30 August 2024

Accepted: 30 October 2024

First Online: 20 November 2024

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below